$49.62
+0.81(1.66%)
Mkt Cap $4.8B
$31.27
$76.78
52-Week Range
At a Glance
AI-generatedCRISPR Therapeutics AG (CRSP) reported FY 2025 total revenue of $3.5M, primarily from collaboration activities, amid heavy R&D investment.
Revenue breakdown: Collaboration Revenue (98.3%), Grant (1.7%).
8-K
CRISPR Therapeutics AG announced on March 10, 2026, that it commenced a private offering, as disclosed in a press release filed as Exhibit 99.1 with the Form 8-K. This event under Item 8.01 provides investors with information on the company's financing activities.$4.8B
Market Cap
$3M
Revenue
-$621M
Net Income
Employees393
Fundamentals
How The Business Makes Money
Revenue by Segment
Collaboration Revenue98.3%($810M)
Grant1.7%($14M)
Activity
What Changed Recently
Company Profile
CIK0001674416
ISINCH0334081137
CUSIPH17182108
Phone41 41 561 32 77
AddressBaarerstrasse 14, Zug, 6300, CH
SEC EDGAR